Are you a journalist? Please sign up here for our press releases
FDA approves third-generation hepatitis B vaccine based on Weizmann research
How does the cell keep certain vital proteins from getting recycled?
Dr. Gad Asher wants to know why our bodies need clocks in every cell.
Bio-Hep-B, a vaccine for hepatitis B based on Prof. Shaul's research, is produced by Biotechnology General and marketed in Israel
Prof. Yosef Shaul was appointed Head of the Molecular Genetics Department.
To live, we all must die a little every day